Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue
Bruzzi, P.
Bmj 316(7139): 1181-1182
1998
ISSN/ISBN: 0959-8138 PMID: 9552991 Document Number: 488555
Document emailed within 1 workday
Related Documents
Page, D.L.; Lagios, M.D. 1995: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ Cancer 75(6): 1219-22; discussion 1223-7Jesani, A.; Coutinho, L. 2007: AIDS vaccine trials in India: ethical benchmarks and unanswered questions Indian Journal of Medical Ethics 4(1): 2-3
1988: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women New England Journal of Medicine 319(26): 1681-1692
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Morrow, M.; Jordan, V.C. 1993: Risk factors and the prevention of breast cancer with tamoxifen Cancer Surveys 18: 211-229
Espie, M. 1995: Prevention of breast cancer: what are the other possibilities under study besides tamoxifen chemoprevention? Contraception Fertilite Sexualite 23(6): 399-403
Marshall, J.G. 2004: Cancer screening in women with chronic illness: the unanswered questions Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 13(2): 110-113
Fosså, S.D. 1995: Tumor cells in peripheral blood and bone marrow in patients with prostatic cancer. Many unanswered questions Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(29): 3599-3600
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Laursen, A. 1992: Unanswered questions Sygeplejersken 92(26): 14; Discussion 15
Stern, R.S. 1984: UV-B. Unanswered questions Archives of Dermatology 120(11): 1437-1439
Gilden, D. 1997: ACTG 300 leaves many questions unanswered Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 11(7-8): 35-36
Wilder-Smith, A.; Earnest, A.; Ma, S.; Ng, L. 2013: Haze and dengue: the unanswered questions Annals of the Academy of Medicine Singapore 42(12): 687-688
Jenkins, G.H. 1987: A few unanswered questions on general practice Practitioner 231(1432): 982
Axelsson, C.K.; Mouridsen, H.T.; Zedeler, K. 1992: Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG) European Journal of Cancer 28a(8-9): 1415-1418
Pickering, T.G. 1997: Lessons from the Trials of Hypertension Prevention, phase II. Energy intake is more important than dietary sodium in the prevention of hypertension Archives of Internal Medicine 157(6): 596-597
Gisselquist, D. 2003: Unanswered questions about sexual transmission of HIV in Mwanza, Tanzania Journal of Acquired Immune Deficiency Syndromes 32(3): 349-51; Author Reply 351
Edan, G. 1998: New therapeutic strategies for multiple sclerosis: unanswered questions Revue Neurologique (Paris) 154(12): 813-815